BioDelivery Sciences to Report First Quarter 2021 Financial Results on May 6, 2021

Rhea-AI Summary

BioDelivery Sciences International (NASDAQ: BDSI) will report its Q1 2021 financial results on May 6, 2021, prior to the U.S. market opening. A conference call will be held at 8:30 AM Eastern Time to discuss these results and business updates. BDSI specializes in developing therapies for chronic conditions, utilizing its innovative BEMA technology for effective treatment solutions. The company focuses on serious health issues like chronic pain and opioid-induced constipation.

RALEIGH, N.C., April 20, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its first quarter 2021 financial results before the open of the U.S. financial markets on Thursday, May 6, 2021. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operations.

Conference Call Dial-In & Webcast Information:

	Date:	Thursday, May 6, 2021
	Time:	8:30 AM Eastern Time
	Domestic:	877-407-0789
	International:	201-689-8562
	Conference ID:	13718097
	Webcast:	http://public.viavid.com/index.php?id=144116

About BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA^®) technology to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. BDSI's marketed products address serious and debilitating conditions, including chronic pain and opioid-induced constipation.

© 2021 BioDelivery Sciences International, Inc.  All rights reserved.

Contact:
Bob Yedid
LifeSci Advisors
646-597-6989
Bob@LifeSciAdvisors.com

 

FAQ

When will BioDelivery Sciences International report its Q1 2021 financial results?

BioDelivery Sciences International will report its Q1 2021 financial results on May 6, 2021.

What time is the conference call for BioDelivery Sciences International's Q1 2021 results?

The conference call for BioDelivery Sciences International's Q1 2021 results is scheduled for 8:30 AM Eastern Time on May 6, 2021.

How can I access the webcast of BioDelivery Sciences International's Q1 2021 financial results?

You can access the webcast of BioDelivery Sciences International's Q1 2021 financial results at http://public.viavid.com/index.php?id=144116.

What is BioDelivery Sciences International's focus in the pharmaceutical industry?

BioDelivery Sciences International focuses on developing therapies for patients with chronic conditions, including chronic pain and opioid-induced constipation.